Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E

Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort) Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort) Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort) Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat. Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July. Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July. Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July. Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July. New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles. New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles. New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles. New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles. New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles. St. John’s wort as Effective as Popular Prescription Anti-Depressant Organization comments on study published Friday February 13th in British Medical Journal. St. John’s wort as Effective as Popular Prescription Anti-Depressant Organization comments on study published Friday February 13th in British Medical Journal. 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis. 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis. 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis. 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis. Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases. Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases. Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases. Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases. Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%. Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%. Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%. Folic Acid May Prevent Hypertension in Addition to Reducing the Risk of Birth Defects JAMA study shows that for younger women who consume at least 1000 micrograms of folic acid the incidence of hypertension is decrased by 46%. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Study Results Show Efficacy of Bioforce’s Prostasan Swiss study of 364 men indicates reduction of symptoms. Study Results Show Efficacy of Bioforce’s Prostasan Swiss study of 364 men indicates reduction of symptoms. Study Results Show Efficacy of Bioforce’s Prostasan Swiss study of 364 men indicates reduction of symptoms. Study Results Show Efficacy of Bioforce’s Prostasan Swiss study of 364 men indicates reduction of symptoms. COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes Company announces partnership project to investigate the potential use of COLD-fX(R) as a "standard of care" for the prevention of upper respiratory infections in Canadian nursing homes. COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes Company announces partnership project to investigate the potential use of COLD-fX(R) as a "standard of care" for the prevention of upper respiratory infections in Canadian nursing homes. COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes Company announces partnership project to investigate the potential use of COLD-fX(R) as a "standard of care" for the prevention of upper respiratory infections in Canadian nursing homes. COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes Company announces partnership project to investigate the potential use of COLD-fX(R) as a "standard of care" for the prevention of upper respiratory infections in Canadian nursing homes. New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury. New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury. New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury. New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury. Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients. Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients. Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients. Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients. Vitamin D Injections May Significantly Improve Survival in Dialysis Patients Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies. Vitamin D Injections May Significantly Improve Survival in Dialysis Patients Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies. Vitamin D Injections May Significantly Improve Survival in Dialysis Patients Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies. Vitamin D Injections May Significantly Improve Survival in Dialysis Patients Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections. Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections. Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections. Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections. Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections. Sunflower Seed Oil Can Protect Low Birth Weight Babies From Infection Massaging low birth weight babies with sunflower seed oil is a low cost intervention that can protect them from infections. Study Reviews Literature to Determine Efficacy of Herbal Supplements in Reducing Illnesses in Children Study concludes after literature review that insufficient data were available for pediatric uses of chamomile, feverfew, ginger, and ginko, but Andrographis paniculata, evening primrose oil, ivy leaf, valerian all had scientific support for use in some conditions. Study Reviews Literature to Determine Efficacy of Herbal Supplements in Reducing Illnesses in Children Study concludes after literature review that insufficient data were available for pediatric uses of chamomile, feverfew, ginger, and ginko, but Andrographis paniculata, evening primrose oil, ivy leaf, valerian all had scientific support for use in some conditions. Study Reviews Literature to Determine Efficacy of Herbal Supplements in Reducing Illnesses in Children Study concludes after literature review that insufficient data were available for pediatric uses of chamomile, feverfew, ginger, and ginko, but Andrographis paniculata, evening primrose oil, ivy leaf, valerian all had scientific support for use in some conditions. Study Reviews Literature to Determine Efficacy of Herbal Supplements in Reducing Illnesses in Children Study concludes after literature review that insufficient data were available for pediatric uses of chamomile, feverfew, ginger, and ginko, but Andrographis paniculata, evening primrose oil, ivy leaf, valerian all had scientific support for use in some conditions. New Study Shows GliSODin® Supplementation Increases SOD Levels and Protects Against Oxidative Stress New study concludes that supplementation with GliSODin® promotes cellular antioxidant status and protects against oxidative stess-induced cell death. New Study Shows GliSODin® Supplementation Increases SOD Levels and Protects Against Oxidative Stress New study concludes that supplementation with GliSODin® promotes cellular antioxidant status and protects against oxidative stess-induced cell death. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	USC Forum Held February 26 Reviewed Body of Research and Makes Recommendations for Future Study on the Health Benefits of Antioxidants LOS ANGELES, March 1, 2005 /PRNewswire via COMTEX/ -- Scientific experts in pharmacology, toxicology and nutrition gathered at the University of Southern California (USC) on February 26 for a forum to discuss the benefits and safety of vitamin E. The group concluded that due to promising results from existing clinical studies, antioxidant supplements are safe and appear to confer a health benefit in certain individuals. Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken. During the day-long forum, scientists discussed topics ranging from the effects of vitamin E on neurological disorders and cardiovascular disease to the overall safety of vitamin E supplementation in the general population and the elderly. Lester Packer, Ph.D., adjunct professor of molecular pharmacology and toxicology at the USC School of Pharmacy and Ishwarlal Jialal, M.D., Ph.D., Robert E. Stowell Endowed Chair in Experimental Pathology and director of the Laboratory for Atherosclerosis and Metabolic Research at UC Davis School of Medicine, led this group of nine scientists in panel discussions reviewing clinical research demonstrating the value of vitamin E supplementation to human health. Vitamin E, a fat-soluble vitamin, acts as an antioxidant to protect cells in the body against the effects of free radicals, which are potentially damaging by-products of cell metabolism. Common food sources of vitamin E include vegetable oils, nuts, green leafy vegetables, and fortified cereals. Current U.S. Department of Agriculture (USDA) guidelines advise that a person's daily intake of vitamin E should be met primarily through food sources, but that many Americans require supplements to get the nutrients they need. Vitamin E supplement capsules typically contain 400 IU to 800 IU. The Institute of Medicine advises adults can consume up to 1500 IU of vitamin E a day. Numerous scientific studies suggest vitamin E supplements offer a variety of health benefits including helping to reduce the risk of heart disease, cancer and Alzheimer's disease. A study conducted by Johns Hopkins University, published in the Journal of Archives of Neurology in 2004 found in 4,740 men and women over age 65 who took daily doses of 500-1500 mg of vitamin C and 400-1000 IU of Vitamin E reduced the prevalence and risk of Alzheimer disease. Vitamins C and E are associated with maintaining the health of brain cells. In November 2004, another John Hopkins meta-analysis found that older patients (47-84 years of age) with existing conditions such as heart disease, Parkinson's disease and kidney disease, who took more than 400 IUs of vitamin E or more per day, had an increased risk of all-cause mortality. But the study noted, "overall, vitamin E supplementation did not affect all cause mortality." The study also concluded, "... high dosage vitamin E trials were often performed in patients with various chronic diseases, and we could not evaluate the generalizability of our findings to healthy adult populations." Referencing the body of clinical research on vitamin E safety, scientists participating in the USC Vitamin E Forum agreed it would be premature to apply this study's isolated findings to the general population. The group urged the scientific community to conduct long-term, large-scale trials on vitamin E supplementation in well-defined populations because they appear to be beneficial to the health of certain individuals. Leiner Health Products and the University of Southern California School of Pharmacy organized the USC Vitamin E Forum. Sponsors included Archer, Daniels, Midland Company; BASF Corporation, China Vitamins LLC, Cognis Nutrition and Health.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software